Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Nimalan Pathmanathan"'
Autor:
Lachlan Allan, MS, MD, Helen Pham, MPH, FRACS, Charlotte Kwik, MBBS, FRACS, Nimalan Pathmanathan, MBBS, MMED, FRACS
Publikováno v:
Radiology Case Reports, Vol 18, Iss 7, Pp 2359-2361 (2023)
Appendiceal diverticulitis is a rare pathology which is distinctly different to acute appendicitis and associated with higher rates of morbidity and mortality. Furthermore, diagnosis is often retrospective on histopathological analysis of appendicect
Externí odkaz:
https://doaj.org/article/2a449a64a06247b7a5b7deca9d30687b
Autor:
James Wei Tatt Toh, Jack Cecire, Kerry Hitos, Karen Shedden, Fiona Gavegan, Nimalan Pathmanathan, Toufic El Khoury, Angelina Di Re, Annelise Cocco, Alex Limmer, Tom Liang, Kar Yin Fok, James Rogers, Edgardo Solis, Grahame Ctercteko
Publikováno v:
Annals of Coloproctology, Vol 38, Iss 1, Pp 36-46 (2022)
Purpose Enhanced Recovery After Surgery (ERAS) has become standard of care in colorectal surgery. However, there is not a universally accepted colorectal ERAS protocol and significant variations in care exist between institutions. The aim of this stu
Externí odkaz:
https://doaj.org/article/f3cfaf97d16d42eeae8ed16badeea933
Autor:
Joseph Do Woong Choi, Charlotte Kwik, Nurojan Vivekanandamoorthy, Aswin Shanmugalingam, Lachlan Allan, Fiona Gavegan, Karen Shedden, Ashleigh Peters, Toufic El Khoury, Nimalan Pathmanathan, James Wei Tatt Toh
Publikováno v:
International Journal of Colorectal Disease. 38
Purpose Preoperative hypoalbuminemia has traditionally been used as a marker of nutritional status and is considered a significant risk factor for anastomotic leak (AL). Methods The Westmead Enhanced Recovery After Surgery (WERAS) prospectively colle
Autor:
James Wei Tatt Toh, Joris Harlaar, Angelina Di Re, Nimalan Pathmanathan, Toufic El Khoury, Grahame Ctercteko
Publikováno v:
Annals of Laparoscopic and Endoscopic Surgery. 4:47-47
Autor:
Stephen Fletcher, Nimalan Pathmanathan
Publikováno v:
Journal of the Intensive Care Society. 12:187-189
We present our experience with drotrecogin alfa (activated) in 110 patients. Data were collected on diagnosis, acuity, complications and outcomes. Crude ICU and hospital mortality was high at 47.3 and 55.5% respectively (hospital SMR = 1.02). Our pat